Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last

Bibliography

• Forsgren L. Prevalence of epilepsy in adults in northern Sweden. Epilepsia 1992;33(3):450-8
   PubMed Web of Science ®Google Scholar
• Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349:1257-66
   PubMed Web of Science ®Google Scholar
• Forsgren L, Beghi E, Oun A, The epidemiology of epilepsy in Europe–a systematic review. Eur J Neurol 2005;12(4):245-53
   PubMed Web of Science ®Google Scholar
• Cockerell OC, Johnson AL, Sander JW, Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346(8968):140-4
   PubMed Web of Science ®Google Scholar
• Mattson RH, Cramer JA, Collins JF, Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51
   PubMed Web of Science ®Google Scholar
• Schiller Y. Seizure relapse and development of drug resistance following long-term seizure remission. Arch Neurol 2009;66(10):1233-9
   PubMedGoogle Scholar
• Glauser T, Ben-Menachem E, Bourgeois B, ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47(7):1094-120
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5(7):553-64
   PubMed Web of Science ®Google Scholar
• Baulac M. New antiepileptic drugs: new therapeutic options. Rev Neurol (Paris) 2002;158(5 Pt 2):4S46-54
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, ; SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1000-15
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Perucca E, Ryvlin P, ; Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68(6):402-8
   PubMed Web of Science ®Google Scholar
• Chadwick D. Valproate in the treatment of partial epilepsies. Epilepsia 1994;35(Suppl 5):S96-8
   Google Scholar
• Crawford P, Chadwick D. A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1986;49(11):1251-7
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Mumford JP. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group. Epilepsy Res 1999;34(2-3):199-205
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Shu V, Wallin B. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group. Neurology 1996;46(1):49-53
   PubMed Web of Science ®Google Scholar
• Perucca E, Yasothan U, Clincke G, Lacosamide. Nat Rev Drug Discov 2008;7(12):973-4
   PubMed Web of Science ®Google Scholar
• Deckers CL, Czuczwar SJ, Hekster YA, Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000;41(11):1364-74
   PubMed Web of Science ®Google Scholar
• Barcs G, Walker EB, Elger CE, Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41(12):1597-607
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E, Biton V, Jatuzis D, Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partialonset seizures. Epilepsia 2007;48:1308-17
   PubMed Web of Science ®Google Scholar
• Matsuo F, Bergen D, Faught E, Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures: U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993;43(11):2284-91
   PubMed Web of Science ®Google Scholar
• Messenheimer J, Ramsay RE, Willmore LJ, Lamotrigine therapy for partial seizures : a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35(1):113-21
   PubMed Web of Science ®Google Scholar
• Schapel GJ, Beran RG, Vajda FJ, Double blind, placebo controlled, cross-over study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56(5):448-53
   PubMed Web of Science ®Google Scholar
• French JA, Kanner AM, Bautista J, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1261-73
   PubMed Web of Science ®Google Scholar
• Faught E, Morris G, Jacobson M, Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group. Epilepsia 1999;40(8):1135-40
   PubMed Web of Science ®Google Scholar
• Buchanan N. Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years. Seizure 1996;5(3):209-14
   PubMedGoogle Scholar
• Brodie MJ, Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 1997;26(3):423-32
   PubMed Web of Science ®Google Scholar
• Marciani MG, Stanzione P, Mattia D, Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998;21(1):41-7
   PubMed Web of Science ®Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ, Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res 2007;73:1-52
   PubMed Web of Science ®Google Scholar
• Chung S, Sperling MR, Biton V, Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures. Epilepsia 2007;48:321
   Web of Science ®Google Scholar
• Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, SP755 Study Group. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009;50(3):443-53
   PubMed Web of Science ®Google Scholar
• Anhut H, Ashman P, Feuerstein TJ, Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a doubleblind, placebo-controlled study: the International Gabapentin Study Group. Epilepsia 1994;35:795-801
   PubMed Web of Science ®Google Scholar
• UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335:1114-7
   PubMed Web of Science ®Google Scholar
• The US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebocontrolled, parallel-group study. Neurology 1993;43:2292-8
   PubMed Web of Science ®Google Scholar
• Sivenius J, Kalviainen R, Ylinen A, Double-blind study of Gabapentin in the treatment of partial seizures. Epilepsia 1991;32:539-42
   PubMed Web of Science ®Google Scholar
• French JA, Kugler AR, Robbins JL, Dose–response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60:1631-7
   PubMed Web of Science ®Google Scholar
• Arroyo S, Anhut H, Kugler AR, Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose–response study in adults with partial seizures. Epilepsia 2004;45:20-7
   PubMed Web of Science ®Google Scholar
• Beydoun A, Uthman BM, Kugler AR, Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475-80
   PubMed Web of Science ®Google Scholar
• Elger CE, Brodie MJ, Anhut H, Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixeddose treatment in a double-blind, placebo-controlled study. Epilepsia 2005;46:1926-36
   PubMed Web of Science ®Google Scholar
• Harden CL, Lazar LM, Pick LH, A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40(8):1129-34
   PubMed Web of Science ®Google Scholar
• Gil-Nagel A, Zaccara G, Baldinetti F, Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials. Seizure 2009;18(3):184-92
   PubMed Web of Science ®Google Scholar
• Oles KS, Penry JK, Cole DL, Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989;30(1):74-8
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E, Henrisksen O, Dam M, Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43
   PubMed Web of Science ®Google Scholar
• Faught E, Wilder BJ, Ramsay RE, Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages: Topiramate YD Study Group. Neurology 1996;46:1684-90
   PubMed Web of Science ®Google Scholar
• Privitera M, Fincham R, Penry J, Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000 mg daily dosages: Topiramate YE Study Group. Neurology 1996;46:1678-83
   PubMed Web of Science ®Google Scholar
• Sharief M, Viteri C, Ben-Menachem E, Double-blind, placebo controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996;25:217-24
   PubMed Web of Science ®Google Scholar
• Schmidt D, Jacob R, Loiseau P, Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67-73
   PubMed Web of Science ®Google Scholar
• Faught E, Ayala R, Montouris G, The Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-9
   PubMed Web of Science ®Google Scholar
• Sackellares JC, Ramsay RE, Wilder BJ, Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004;45:610-7
   PubMed Web of Science ®Google Scholar
• Ziemann AE, Schnizler MK, Albert GW, Seizure termination by acidosis depends on ASIC1a. Nat Neurosci 2008;11(7):816-22
   PubMed Web of Science ®Google Scholar
• Varadkar S, Duncan JS, Cross JH. Acetazolamide and autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003;44(7):986-7
   PubMed Web of Science ®Google Scholar
• Lombroso CT, Davidson DT Jr, Gross-Bianchi ML. Further evaluation of acetazolamide (Diamox) in treatment of epilepsy. JAMA 1956;160:268-72
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Jallon P. Traitement médical des épilepsies in Traité de Neurologie. Epilepsies, Ed. DOIN Groupe Liaisons; 2007. p. 275-298
   Google Scholar
• Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(Suppl 1):S66-71
   PubMedGoogle Scholar
• Baulac M, Leppik IE. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Epilepsy Res 2007;75(2-3):75-83
   PubMed Web of Science ®Google Scholar
• Shorvon SD, Lowenthal A, Janz D, Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures: European Levetiracetam Study Group. Epilepsia 2000;41:1179-86
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/day in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-83
   PubMed Web of Science ®Google Scholar
• Betts T, Waegemans T, Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9:80-7
   PubMed Web of Science ®Google Scholar
• Boon P, Chauvel P, Pohlmann-Eden B, Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy Res 2002;48(1-2):77-89
   PubMed Web of Science ®Google Scholar
• Wilensky AJ, Ojemann LM, Temkin NR, Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study. Neurology 1981;31(10):1271-6
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Mumford JP. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group. Epilepsy Res 1999;34(2-3):199-205
   PubMed Web of Science ®Google Scholar
• Schmidt D, Rohde M, Wolf P, Clobazam for refractory focal epilepsy. A controlled trial. Arch Neurol 1986;43(8):824-6
   PubMedGoogle Scholar
• Farhat G, Yamout B, Mikati MA, Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58(9):1348-53
   PubMed Web of Science ®Google Scholar
• Trimble MR. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987;28(Suppl 3):S37-45
   Google Scholar
• Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003;2(6):347-56
   PubMed Web of Science ®Google Scholar
• Grünewald RA, Thompson PJ, Corcoran R, Effects of vigabatrin on partial seizures and cognitive function. J Neurol Neurosurg Psychiatry 1994;57(9):1057-63
   PubMed Web of Science ®Google Scholar
• Kälviäinen R, Nousiainen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 2001;15(3):217-30
   PubMed Web of Science ®Google Scholar
• Jammoul F, Wang Q, Nabbout R, Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol 2009;65(1):98-107
   PubMed Web of Science ®Google Scholar
• O'brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005;66(Suppl 2):28-33
   PubMedGoogle Scholar
• Biraben A, Allain H, Scarabin JM, Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2000;55:1757-8
   Web of Science ®Google Scholar
• French JA, Kanner AM, Bautista J, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1252-60
   PubMed Web of Science ®Google Scholar
• Benbadis SR. The management of idiopathic generalized epilepsies. Acta Neurol Scand Suppl 2005;181:63-7
   PubMedGoogle Scholar
• Perucca E. The management of refractory idiopathic epilepsies. Epilepsia 2001;42(Suppl 3):31-5
   PubMedGoogle Scholar
• Beran RG, Berkovic SF, Dunagan FM, Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 1998;39(12):1329-33
   PubMed Web of Science ®Google Scholar
• Gericke A, Picard F, De Saint-Martin A, Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-eeg-controlled, open study. Epileptic Disord 1999;1(3):159-65
   PubMed Web of Science ®Google Scholar
• Berkovic SF, Knowlton RC, Leroy RF, Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Levetiracetam N01057 Study Group. Neurology 2007;69:1751-60
   PubMed Web of Science ®Google Scholar
• Noachtar S, Andermann E, Meyvisch P, N166 levetiracetam study group Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-16
   PubMed Web of Science ®Google Scholar
• Perucca E, Gram L, Avanzini G, Antiepileptic drugs as a cause of worsening of seizures. Epilepsia 1998;39:5-17
   PubMed Web of Science ®Google Scholar
• Biton V, Montouris GD, Ritter F, A randomized, placebo-controlled study of topiramate in primary generalized tonic—clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-7
   PubMed Web of Science ®Google Scholar
• Biton V, Bourgeois BF, YTC/YTCE Study Investigators. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol 2005;62(11):1705-8
   Google Scholar
• Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990;40(11):1677-81
   PubMed Web of Science ®Google Scholar
• Kothare SV, Kaleyias J. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Expert Opin Drug Metab Toxicol 2008;4(4):493-506
   PubMed Web of Science ®Google Scholar
• Beghi E, Gatti G, Tonini C, et al; BASE Study Group. Adjunctive therapy vs. alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res 2003;57(1):1-13
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342(5):314-9
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002;58(8 Suppl 5):S2-8
   Web of Science ®Google Scholar
• Semah F, Picot MC, Adam C, Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51(5):1256-62
   PubMed Web of Science ®Google Scholar
• Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 2008;70(1):54-66
   PubMed Web of Science ®Google Scholar
• French JA, Faught E. Rational polytherapy. Epilepsia 2009;50(Suppl 8):63-8
   PubMedGoogle Scholar
• Devinsky O. Patients with refractory seizures. N Engl J Med 1999;340(20):1565-70
   PubMed Web of Science ®Google Scholar
• Kwan P, Arzimanoglou A, Berg AT, Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2009 [Epub ahead of print]
   Google Scholar
• Langfitt JT, Wiebe S. Early surgical treatment for epilepsy. Curr Opin Neurol 2008;21(2):179-83
   PubMed Web of Science ®Google Scholar